Impact of the Treating Institution on Survival of Patients With "Poor-Prognosis" Metastatic Nonseminoma

Abstract

Patients treated in institutions that entered fewer than five patients into the trial appeared to have poorer survival than those treated in institutions that entered a larger number of patients with "poor-prognosis" nonseminoma.